Fundraising FoxHM Venture Partners — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Arthrosiarthrosi.comOct 2025 · $153M
Arthrosi Therapeutics is a clinical-stage biopharmaceutical company developing treatments for gout, an inflammatory arthritis condition.
BiotechDigital HealthMedical DevicesSan Diego, US
Litain Yeh(Co-Founder & Chief Executive Officer)inShunqi Yan(Co-Founder & Chief Operating Officer)Robert Orr(Executive Officer, Director, Promoter)Yiwei Zong(Director)Jianfeng Fang(Director)
BoardZhang Mingyuan(Director)
Co-investorsMaxpro VenturesHighlight Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.